In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coronavirus-Driven Regulatory Changes Put Telehealth On The Map

Experts Predict Telehealth Will Become The New Normal

Executive Summary

Adoption of telehealth services has skyrocketed during the coronavirus outbreak and US experts are expecting the trend to continue post-pandemic, fundamentally transforming health care.

You may also be interested in...



Telehealth Sees Skyrocketing Demand Amid Regulatory Expansion, Hopes To Last Beyond COVID-19 Crisis

US telehealth companies are seeing skyrocketing demand for devices and services, which offers opportunities and challenges during this COVID-19 crisis.

Acutus Medical Inks Marketing Deal With Biotronik, Mapping Its Way To Electrophysiologists Outside US

Biotronik will help Acutus to bring its cardiac mapping software and guidance system to electrophysiologists worldwide.

Interview: Lessons Learned From The Pandemic And Five Strategies For Medtech’s Recovery

In an interview with Medtech Insight, two Ernst & Young health care leaders outline five trends for medtech companies to redefine their business models in response to COVID-19.

Topics

UsernamePublicRestriction

Register

LL021506

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel